Rubicon Organics Inc (FRA:R07)
€ 0.282 -0.006 (-2.08%) Market Cap: 16.34 Mil Enterprise Value: 17.26 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 38/100
Back to the Transcripts List

Q2 2024 Rubicon Organics Inc Earnings Call Transcript

Aug 15, 2024 / 02:00PM GMT
Release Date Price: €0.304 (-0.65%)

Key Points

Positve
  • Rubicon Organics Inc (ROMJF) achieved a historic high in net revenue for Q2 2024, totaling $12.1 million.
  • The company returned to positive adjusted EBITDA and operating cash flow following a subdued Q1.
  • Rubicon Organics Inc (ROMJF) maintained its number-one premium market position in Canada across all categories.
  • The company captured 30% of the premium edibles market within a year of launch.
  • Rubicon Organics Inc (ROMJF) achieved 40% national distribution for its vapes in just two months since launch.
Negative
  • Gross margin decreased to 30% in Q2 2024 due to market trends such as price compression and a shift towards lower-priced larger formats.
  • The ERP implementation project has depressed adjusted EBITDA for both quarters in 2024.
  • 1964 brand faced tough market conditions and pricing pressures, leading to mixed performance.
  • Investments in ERP and other projects have impacted cash flow and profitability in the short term.
  • The company is facing ongoing price pressures and adverse product mix shifts towards lower-margin categories.
Operator

Good morning, ladies and gentlemen, and welcome to Rubicon Organics Q2 earnings conference call. (Operator Instructions) This call is being recorded on Thursday, August 15, 2024.

I would now like to turn the conference over to Margaret Brody. Please go ahead.

Margaret Brodie
Rubicon Organics Inc - Chief Executive Officer, Director

Thank you, and good morning, everyone. Today, I'll provide an update on Rubicon Organics and the performance in Q2 '24, highlighting our progress as the premium leader in Canadian cannabis and discuss our growth and unique opportunities for 2024 and beyond.

Rubicon has achieved another robust quarter, recording a historic high in net revenue and marking a return to positive adjusted EBITDA and operating cash flow following a subdued Q1. As the leading premium licensed producers, Rubicon continues to hold a strong market share in premium flower and pre-rolls, premium edibles and the topical market. We anticipate further growth in 2024, supported by our successful late launch of two SKUs in May with a further genetic

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.